121 related articles for article (PubMed ID: 552102)
1. Protective effects of a novel thromboxane analog in lethal traumatic shock.
Lefer AM; Araki H; Smith JB; Nicolaou KC; Magolda RL
Prostaglandins Med; 1979 Sep; 3(3):139-46. PubMed ID: 552102
[TBL] [Abstract][Full Text] [Related]
2. Preservation of ischemic myocardium by pinane thromboxane A2.
Schrör K; Smith EF; Bickerton M; Smith JB; Nicolaou KC; Magolda R; Lefer AM
Am J Physiol; 1980 Jan; 238(1):H87-92. PubMed ID: 7356037
[TBL] [Abstract][Full Text] [Related]
3. Efficacy of a combination thromboxane receptor antagonist and lipoxygenase inhibitor in traumatic shock.
Levitt MA; Stahl G; Lefer AM
Resuscitation; 1988 Jul; 16(3):211-20. PubMed ID: 2845544
[TBL] [Abstract][Full Text] [Related]
4. Beneficial effect of a thromboxane synthetase inhibitor in traumatic shock.
Hock CE; Lefer AM
Circ Shock; 1984; 14(3):159-68. PubMed ID: 6542462
[TBL] [Abstract][Full Text] [Related]
5. Protective actions of nafazatrom in traumatic shock.
Lefer AM; Messenger M
Arzneimittelforschung; 1982; 32(9):1089-91. PubMed ID: 6890831
[TBL] [Abstract][Full Text] [Related]
6. Protective effects of a combination thromboxane synthesis inhibitor-receptor antagonist, R-68070, during murine traumatic shock.
Aoki N; Johnson G; Siegfried MR; Lefer AM
Eicosanoids; 1989; 2(3):169-74. PubMed ID: 2534278
[TBL] [Abstract][Full Text] [Related]
7. Salutary effects of anisodamine in murine traumatic shock.
Hock CE; Su JY; Lefer AM
Circ Shock; 1983; 11(3):211-6. PubMed ID: 6652878
[TBL] [Abstract][Full Text] [Related]
8. Protective action of 6-keto-prostaglandin E1 in traumatic shock.
Araki H; Lefer AM
Prostaglandins Med; 1979 Apr; 2(4):277-84. PubMed ID: 575862
[TBL] [Abstract][Full Text] [Related]
9. Protective effects of a new LTD4 antagonist (LY-171883) in traumatic shock.
Hock CE; Lefer AM
Circ Shock; 1985; 17(4):263-72. PubMed ID: 3841503
[TBL] [Abstract][Full Text] [Related]
10. Protective effects of KW-3635, a novel thromboxane A2 antagonist, in murine traumatic shock.
Karasawa A; Taylor PA; Lefer AM
Eur J Pharmacol; 1990 Jun; 182(1):1-8. PubMed ID: 2401310
[TBL] [Abstract][Full Text] [Related]
11. Beneficial actions of BN 50739, a new PAF receptor antagonist, in murine traumatic shock.
Karasawa A; Rochester JA; Lefer AM
Methods Find Exp Clin Pharmacol; 1990 May; 12(4):231-7. PubMed ID: 2165204
[TBL] [Abstract][Full Text] [Related]
12. Beneficial effects of BAY u3405, a novel thromboxane A2 receptor antagonist, in splanchnic artery occlusion shock.
Canale P; Squadrito F; Altavilla D; Ioculano M; Campo GM; Squadrito G; Urna G; Sardella A; Caputi AP
Pharmacology; 1994 Dec; 49(6):376-85. PubMed ID: 7878075
[TBL] [Abstract][Full Text] [Related]
13. Beneficial actions of prostacyclin in traumatic shock.
Lefer AM; Sollott SL; Galvin MJ
Prostaglandins; 1979 May; 17(5):761-7. PubMed ID: 386429
[TBL] [Abstract][Full Text] [Related]
14. Protective actions of aprotinin in acute traumatic shock.
Araki H; Lefer AM
Arch Int Pharmacodyn Ther; 1979 Oct; 241(2):316-23. PubMed ID: 316692
[TBL] [Abstract][Full Text] [Related]
15. Protective effects of a platelet activating factor (PAF) antagonist and its combined treatment with prostaglandin (PG) E1 in traumatic shock.
Terashita Z; Stahl GL; Lefer AM
J Cardiovasc Pharmacol; 1988; 12(5):505-11. PubMed ID: 2468048
[TBL] [Abstract][Full Text] [Related]
16. Synthesis of stable thromboxane A2 analogs: pinane thromboxane A2 (PTA2) and carbocyclic thromboxane A2 (CTA2).
Nicolaou KC; Magolda RL
Methods Enzymol; 1982; 86():400-9. PubMed ID: 7132765
[No Abstract] [Full Text] [Related]
17. Anti-thromboxane A2 actions of pinane thromboxane A2 derivatives.
Roth DM; Lefer AM; Smith JB; Nicolaou KC
Prostaglandins Leukot Med; 1982 Nov; 9(5):503-9. PubMed ID: 6960376
[TBL] [Abstract][Full Text] [Related]
18. Beneficial effects of a neutral protease inhibitor in traumatic shock.
Hock CE; Lefer AM
Pharmacol Res Commun; 1985 Mar; 17(3):217-26. PubMed ID: 4011646
[TBL] [Abstract][Full Text] [Related]
19. Synthesis and biological properties of pinane-thromboxane A2, a selective inhibitor of coronary artery constriction, platelet aggregation, and thromboxane formation.
Nicolaou KC; Magolda RL; Smith JB; Aharony D; Smith EF; Lefer AM
Proc Natl Acad Sci U S A; 1979 Jun; 76(6):2566-70. PubMed ID: 288046
[TBL] [Abstract][Full Text] [Related]
20. Glucocorticoid induced protection in experimental traumatic shock.
Sollott SJ; Galvin MJ; Lefer AM
Proc Soc Exp Biol Med; 1979 Mar; 160(3):317-20. PubMed ID: 432240
[No Abstract] [Full Text] [Related]
[Next] [New Search]